title: Effects of dietary sodium butyrate on hepatic biotransformation and pharmacokinetics of erythromycin in chickens.
abstract: Butyrate, a commonly applied feed additive in poultry nutrition, can modify the expression of certain genes, including those encoding cytochrome P450 (CYP) enzymes. In comparative in vitro and in vivo experiments, the effect of butyrate on hepatic CYP genes was examined in primary cultures of chicken hepatocytes and in liver samples of chickens collected from animals that had been given butyrate as a feed additive. Moreover, the effect of butyrate on the biotransformation of erythromycin, a marker substance for the activity of enzymes of the CYP3A family, was investigated in vitro and in vivo. Butyrate increased the expression of the avian-specific CYP2H1 both in vitro and in vivo. In contrast, the avian CYP3A37 expression was decreased in hepatocytes following butyrate exposure, but not in the in vivo model. CYP1A was suppressed by butyrate in the in vitro experiments, and overexpressed in vivo in butyrate-fed animals. The concomitant incubation of hepatocytes with butyrate and erythromycin led to an increased CYP2H1 expression and a less pronounced inhibition of CYP3A37. In in vivo pharmacokinetic experiments, butyrate-fed animals given a single i.m. injection of erythromycin, a slower absorption phase (longer T(half-abs) and delayed T(max)) but a rapid elimination phase of this marker substrate was observed. Although these measurable differences were detected in the pharmacokinetics of erythromycin, it is unlikely that a concomitant application of sodium butyrate with erythromycin or other CYP substrates will cause clinically significant feed-drug interaction in chickens.
authors.affiliation: Department of Pharmacology and Toxicology, Faculty of Veterinary Science, Szent István University, Budapest, Hungary.
authors.forename: G
authors.initials: G
authors.lastname: Csikó
authors.forename: G
authors.initials: G
authors.lastname: Nagy
authors.forename: G
authors.initials: G
authors.lastname: Mátis
authors.forename: Z
authors.initials: Z
authors.lastname: Neogrády
authors.forename: Á
authors.initials: Á
authors.lastname: Kulcsár
authors.forename: A
authors.initials: A
authors.lastname: Jerzsele
authors.forename: K
authors.initials: K
authors.lastname: Szekér
authors.forename: P
authors.initials: P
authors.lastname: Gálfi
mesh_terms: D000821:Animal Feed; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000493:pharmacokinetics; D001711:Biotransformation; D020148:Butyric Acid / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000494:pharmacology*; D002478:Cells, Cultured; D002645:Chickens / Q000378:metabolism*; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004032:Diet / Q000662:veterinary; D004347:Drug Interactions; D004917:Erythromycin / Q000008:administration & dosage / Q000493:pharmacokinetics*; D005260:Female; D015971:Gene Expression Regulation, Enzymologic; D022781:Hepatocytes / Q000187:drug effects / Q000378:metabolism; D006633:Histamine Antagonists / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology; D008099:Liver / Q000378:metabolism*; D008297:Male; D008562:Membrane Glycoproteins; D017472:Receptors, Interleukin-1
chemical_list: D000900:Anti-Bacterial Agents; D006633:Histamine Antagonists; D008562:Membrane Glycoproteins; D017472:Receptors, Interleukin-1; C434984:TIRAP protein, human; D020148:Butyric Acid; D004917:Erythromycin; D003577:Cytochrome P-450 Enzyme System